文献

J-GLOBAL ID：201202211790196080   整理番号：12A0906787

切除不能な進行性膵臓癌の治療におけるゲムシタビンとS-1の併用療法対ゲムシタビン単独療法の無作為化第II相試験(日本がん臨床試験推進機構のPC-01試験)

Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)

著者 (21件)： OZAKA Masato (Cancer Inst. Hospital, Dep. of Gastroenterology, 3-8-31 Ariake, Koto-ku, 135-8550, Tokyo, JPN) ,  MATSUMURA Yuji (Juntendo Univ. School of Medicine, Dep. of Gastroenterology, 2-1-1 Hongo, Bunkyo-ku, 113-8421, Tokyo, JPN) ,  ISHII Hiroshi (Cancer Inst. Hospital, Dep. of Gastroenterology, 3-8-31 Ariake, Koto-ku, 135-8550, Tokyo, JPN) ,  OMURO Yasushi (Komagome Hospital, Dep. of Chemotherapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, 3-18-22 ...) ,  ITOI Takao (Tokyo Medical Univ. Hospital, Dep. of Gastroenterology and Hepatology, 6-7-1, Nishi-Shinjuku, Shinjuku-ku, 160-0023 ...) ,  MOURI Hisatsugu (Kanazawa Univ., Cancer Center, 13-1, Takara-machi, 920-0934, Kanazawa, Ishikawa, JPN) ,  HANADA Keiji (JA Onomichi General Hospital, Dep. of Gastroenterology, 1-10-23 Hirahara, 722-8508, Onomichi, Hiroshima, JPN) ,  KIMURA Yasutoshi (Sapporo Medical Univ. School of Medicine, Dep. of Surgical Oncology and Gastroenterological Surgery, South-1 ...) ,  MAETANI Iruru (Toho Univ. Ohashi Medical Center, Div. of Gastroenterology, Dep. of Internal Medicine, 2-17-6 Ohashi, Meguro ...) ,  OKABE Yoshinobu (Kurume Univ., Div. of Gastroenterology, Dep. of Medicine, School of Medicine, 67 Asahi-machi, 830-0011, Kurume ...) ,  TANI Masaji (Wakayama Medical Univ., Second Dep. of Surgery, School of Medicine, 811-1 Kimiidera, 641-8510, Wakayama, JPN) ,  IKEDA Takaaki (Yokosuka Kyosai Hospital, Dep. of Gastroenterology, 1-16 Yonegahamadori, 238-8558, Yokosuka, Kanagawa, JPN) ,  HIJIOKA Susumu (Kumamoto Red Cross Hospital, Dep. of Gastroenterology, 2-1-1, Nagamine-minami, 861-8520, Kumamoto, JPN) ,  WATANABE Ryouhei (Matsuyama Shimin Hospital, Dep. of Surgery, 2-6-5 Ote-machi, 790-0067, Matsuyama, Ehime, JPN) ,  OHOKA Shinya (Tokyo Medical and Dental Univ., Dep. of Gastroenterology and Hepatology, 1-5-45, Yushima, Bunkyo-ku, 113-8519, Tokyo ...) ,  HIROSE Yuki (Japanese Red Cross Fukui Hospital, Dep. of Surgery, 2-4-1 Tsukimi, Fukui-shi, 918-8501, Fukui, JPN) ,  SUYAMA Masafumi (Juntendo Univ. School of Medicine, Dep. of Gastroenterology, 2-1-1 Hongo, Bunkyo-ku, 113-8421, Tokyo, JPN) ,  EGAWA Naoto (Komagome Hospital, Dep. of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center, 3-18-22 ...) ,  SOFUNI Atsushi (Tokyo Medical Univ. Hospital, Dep. of Gastroenterology and Hepatology, 6-7-1, Nishi-Shinjuku, Shinjuku-ku, 160-0023 ...) ,  IKARI Takaaki (Tobu Chiiki Hospital Tokyo Metropolitan Health and Medical Treatment Corp., Dep. of Internal Medicine, 5-14-1 ...) ,  NAKAJIMA Toshifusa (Japan Clinical Cancer Res. Organization, 3-8-31 Ariake, Koto-ku, 135-8550, Tokyo, JPN)
資料名： Cancer Chemotherapy and Pharmacology  (Cancer Chemotherapy and Pharmacology)
巻： 69  号： 5  ページ： 1197-1204  発行年： 2012年05月 
JST資料番号： D0065D  ISSN： 0344-5704  CODEN： CCPHDZ  資料種別： 逐次刊行物 (A)
発行国： ドイツ (DEU)  言語： 英語 (EN)

タイトルに関連する用語 (13件)： 膵臓癌 ,  治療 ,  ゲムシタビン ,  S-1 ,  併用療法 ,  単独療法 ,  第II相試験 ,  日本 ,  がん ,  臨床試験 ,  推進 ,  PC ,  試験